USP〈1151〉 PHARMACEUTICAL DOSAGE FORMS

BRIEFING

〈1151〉 Pharmaceutical Dosage Forms. This proposal is based on the version of the chapter official as of May 1, 2021. The changes made in this revision include:

Inclusion of new dosage forms—Cloths, Sponges, and Swabs.

Updates to Suspensions with new suspensions that include lipid nanoparticles (LNP), and viral vectored vaccines and gene therapies (e.g., adenovirus and adeno-associated virus, respectively).

Updates to the term "TDS", which includes both transdermal delivery systems and topical delivery systems, under Systems.

Updates to Tablets to include a tablet with a sensor to detect if the tablet has been administered.

Updates to Orally Disintegrating Tablets to improve clarity.

Updates to the Glossary to include new dosage forms and updates to Suspensions.

Source from USP and Please refer to USP for details:

https://online.uspnf.com/uspnf/document/2_GUID-431F93A9-1FEC-42AE-8556-AA5B604B2E36_80101_en-US?

hdpe bottles for pharmaceuticals

desiccant bottle with silica gel

144mm*29mm effervescent tube packaging